| Literature DB >> 25888845 |
Annette Peters1,2, Regina Hampel3, Josef Cyrys4,5, Susanne Breitner6, Uta Geruschkat7, Ute Kraus8, Wojciech Zareba9, Alexandra Schneider10.
Abstract
BACKGROUND: The health effects of short-term exposure to ambient ultrafine particles in micro-environments are still under investigation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25888845 PMCID: PMC4379544 DOI: 10.1186/s12989-015-0083-7
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Description of study participants and 5-minute ECG measures
|
|
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||||
| Age (years) | 66.0 | (8.1) | 66.8 | (6.7) | 65.3 | (9.4) | 0.47a | ||||
| BMI (kg/m2) | 30.0 | (4.7) | 30.8 | (4.3) | 29.3 | (4.9) | 0.18a | ||||
|
|
|
|
|
|
| ||||||
| BMI (kg/m2) | ≤30 | 34 | (53) | 15 | (47) | 19 | (59) | 0.32b | |||
| >30 | 30 | (47) | 17 | (53) | 13 | (41) | |||||
| Smoking | never smoker | 26 | (41) | 10 | (31) | 16 | (50) | 0.20c | |||
| ex smoker | 37 | (58) | 21 | (66) | 16 | (50) | |||||
| occasional smoker | 1 | (2) | 1 | (3) | 0 | (0) | |||||
| Employed | no | 50 | (78) | 27 | (84) | 23 | (72) | 0.23b | |||
| yes | 14 | (22) | 5 | (16) | 9 | (28) | |||||
| HbA1c | <6.5% | 49 | (77) | 18 | (56) | 31 | (97) | <0.0001c | |||
| ≥6.5% | 15 | (23) | 14 | (44) | 1 | (3) | |||||
| History of | Coronary heart disease | 4 | (6) | 3 | (9) | 1 | (3) | 0.61c | |||
| Angina pectoris | 5 | (8) | 2 | (6) | 3 | (9) | 1.00c | ||||
| Myocardial infarction | 6 | (9) | 5 | (16) | 1 | (3) | 0.20c | ||||
| Hypertension | 41 | (64) | 21 | (66) | 20 | (63) | 0.79b | ||||
| None of these diseases | 21 | (33) | 9 | (28) | 12 | (38) | 0.42b | ||||
| Medication use | Antidiabetics | 18 | (28) | 17 | (53) | 1 | (3) | <0.0001c | |||
| Beta blockers | 19 | (30) | 12 | (38) | 7 | (22) | 0.17b | ||||
| Statins | 13 | (20) | 10 | (31) | 3 | (9) | 0.06c | ||||
| None of the above | 28 | (44) | 6 | (19) | 22 | (69) | <0.0001c | ||||
| ECG |
|
|
|
|
|
|
|
|
| ||
| 5 min-intervals | HR | 14,874 | 79.3 | (15.6) | 7,312 | 77.7 | (15.6) | 7,562 | 80.8 | (15.4) | <0.0001a |
| RMSSD | 14,874 | 30.8 | (30.1) | 7,312 | 28.0 | (27.3) | 7,562 | 33.5 | (32.3) | <0.0001a | |
| SDNN | 14,874 | 47.1 | (25.1) | 7,312 | 45.9 | (24.6) | 7,562 | 48.2 | (25.5) | <0.0001a | |
| 1 h-intervals | HR | 1,203 | 79.1 | (14.4) | 597 | 77.3 | (14.4) | 606 | 80.8 | (14.1) | <0.0001a |
| RMSSD | 1,203 | 33.9 | (31.7) | 597 | 32.5 | (32.2) | 606 | 35.1 | (31.2) | 0.16a | |
| SDNN | 1,203 | 76.7 | (27.1) | 597 | 77.5 | (26.0) | 606 | 76.0 | (28.2) | 0.32a | |
IGT: impared glucose tolerance, SD: standard deviation, BMI: body mass index, HR: heart rate, RMSSD: root mean square of successive differences, SDNN: standard deviation of NN-intervals, at-test, bChi-square test, cFisher’s exact test.
Antidiabetic medications include: insulins and analogues for injection and inhalation.
Description of personal 5-minute particle measurements from 191 study visits and 1 hour of ambient particle measurements and meteorology recorded between March 2007 and December 2008
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| PNC [N/cm3] | 11,872 | 20,822 ± 39,233 | 521 | 6,354 | 11,134 | 21,987 | 698,225 | 15,633 |
|
| ||||||||
| UFP [N/cm3] | 14,699 | 9,518 ± 6,902 | 937 | 4,892 | 7,629 | 12,049 | 80,858 | 7,157 |
| ACP [N/cm3] | 14,699 | 2,060 ± 1,535 | 88 | 1,020 | 1,657 | 2,615 | 17,377 | 1,595 |
| PM10 [μg/m3] | 15,466 | 18.3 ± 14.1 | 0.0 | 8.4 | 15.3 | 24.4 | 159.8 | 16.0 |
| PM2.5 [μg/m3] | 15,461 | 13.7 ± 11.2 | 0.0 | 5.8 | 10.9 | 18.1 | 106.5 | 12.3 |
| Air temperature [°C] | 15,398 | 10.8 ± 7.9 | −8.4 | 4.7 | 10.8 | 16.5 | 33.8 | 11.8 |
| Relative humidity [%] | 15,398 | 76.9 ± 18.3 | 21.0 | 63.3 | 81.3 | 92.8 | 100.0 | 29.5 |
SD: standard deviation, IQR: interquartile range, PNC: Particle number concentrations, PM10: particulate matter with an aerodynamic diameter <10 μm, PM2.5: particulate matter with an aerodynamic diameter <2.5 μm, ACP: accumulation mode particles (100–800 nm), UFP: ultrafine particles (10-100 nm).
Figure 1Example of personal measurements of PNC. Data was collected starting and ending at the KORA Study Center on November 27th 2007.
Associations between personal measurements of 5-minute average particle number concentrations and 5-minute ECG-measures
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| −0.06 | −0.18; 0.07 | 0.23** | 0.11; 0.36 | 0.16* | 0.04; 0.28 | −0.01 | −0.13; 0.11 |
|
| −0.56* | −1.02; −0.09 | 0.36 | −0.11; 0.83 | 0.02 | −0.45; 0.48 | −0.15 | −0.62; 0.32 |
|
| −0.13 | −0.74; 0.48 | 0.08 | −0.54; 0.70 | 0.14 | −0.48; 0.77 | −0.16 | −0.77; 0.46 |
Analyses considered concurrent and up to 15-minutes delayed exposures and adjusted for trend, meteorology and time of day. Effect estimates are shown for an increase of 16,000 particles cm−3.
*p-value <0.05, **p-value <0.01, CI: confidence interval, HR: heart rate, RMSSD: root mean square of successive differences, SDNN: standard deviation of NN intervals.
Figure 2Effects of personally measured 5-minute PNC on SDNN based on 5-minute ECG recordings in patients with diabetes or impaired glucose tolerance. Effect estimates are shown for an increase of 16,000 particles cm−3.
Associations between ambient 1-hour average air pollution concentrations at the central monitoring site and 1-hour average ECG-measures
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Personal PNC | 0.13 | −0.19; 0.45 | −0.93† | −2.01; 0.16 | 0.53 | −0.70;1.77 |
| UFP | 0.40 | −0.16; 0.95 | 0.99 | −0.66; 2.64 | −0.12 | −2.40; 2.21 |
| ACP | 0.35 | −0.39; 1.09 | −0.30 | −2.23; 1.64 | −1.58 | −5.19; 2.18 |
| PM10 | 0.67 | −0.20; 1.54 | −2.78* | −4.98; −0.59 | −5.00* | −8.88; −0.95 |
| PM2.5 | 0.63 | −0.44; 1.71 | −3.27* | −5.84; −0.69 | −6.86** | −11.73; −1.72 |
Analyses considered concurrent exposures and adjusted for trend, meteorology and time of day. Effect estimates are shown for an increase in interquartile range as given in Table 2.
†p-value <0.1, *p-value <0.05, **p-value <0.01, CI: confidence interval, HR: heart rate, RMSSD: root mean square of successive differences, SDNN: standard deviation of NN-intervals, PNC: Particle number concentrations, PM10: particulate matter with an aerodynamic diameter <10μm, PM2.5: particulate matter with an aerodynamic diameter <2.5μm, UFP: ultrafine particles (10-100μm); ACP: accumulation mode particles (100-800 nm).
Figure 3Two pollutant models for 5-minute personal PNC and 1-hour ambient PM on 5-minute HR and HRV parameters. in patients with diabetes or impaired glucose tolerance. Effect estimates are shown for an increase of 16,000 particles cm−3 and 12 μg m−3 PM2.5.
Figure 4Sensitivity analyses of the association between concurrent exposure to personally measured PNC and SDNN. *Regression coefficient as reported in Table 3.